Ustekinumab provides sustained clinical benefits through 1 year among patients with systemic lupus erythematosus, with a safety profile similar with its other indications, according to data published in Arthritis & Rheumatology.“Treatment options for SLE remain limited,” Ronald F. van Vollenhoven, MD, PhD, of Amsterdam University Medical Centers, told Healio Rheumatology.
SAN FRANCISCO — Both dyspnea and respiratory drive went down with vs. without nasal high-flow therapy in orally intubated patients, according to research presented at…
CHICAGO — A subdivision of the American Diabetes Association has begun publishing a document that aims to provide comprehensive guidance for the treatment of obesity.…
Congress passing the controversial One Big Beautiful Bill Act could leave millions without insurance and lead to at least 16,000 annual preventable deaths, according to…
PHOENIX — Biodegradable nitrile gloves are as safe and reliable as standard gloves and, according to a presenter, offer an opportunity to reduce the amount…
KIAWAH ISLAND, S.C. — In this exclusive Healio Video Perspective from Kiawah Eye, P. Dee Stephenson, MD, FACS, discusses toric IOL rotation and tips for…
Advance your clinical knowledge and earn free CME credits online at Healio.com. Choose from hundreds of activities and print your CME certificates instantly.
Fecal microbiota transplantation was not effective at inducing clinical or endoscopic remission in patients with Crohn’s disease, according to study results published in The American…
Jonathan D. Leffert, MD, talks with Peter A. Bogdanow, a partner at Katten Muchin Rosenman LLP in Dallas, about how private equity firms acquire physician…
The American College of Lifestyle Medicine published new clinical guidance on lifestyle interventions for the treatment and remission of type 2 diabetes and prediabetes.The guidance,…
GLP-1 receptor agonists may significantly reduce the risk for cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors, according to data presented…
